Apricus Biosciences Inc news

   Watch this stock
Showing stories 1 - 10 of about 22   

Articles published

APRI 1.64 -0.07 (-4.09%)
price chart
Apricus Biosciences: A Screaming Buy Or A Falling Knife?
Apricus Biosciences, Inc. (NASDAQ:APRI) recently began their launch of Vitaros, a topical treatment for Erectile Dysfunction (NYSE:ED), with availability in the UK, Sweden, and now Germany.
Apricus Biosciences to Present at the Rodman & Renshaw 16th Annual Global ...
SAN DIEGO, Sept. 3, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines to meet the needs of patients, today announced that Richard Pascoe, Chief Executive Officer, will ...
Related articles »  
Apricus Biosciences To Present At Rodman & Renshaw Conference;Webcast ...
(RTTNews.com) - Apricus Biosciences, Inc.( APRI ) will present at the Rodman & Renshaw Annual Global Investment Conference in New York Palace Hotel, New York City.
Related articles »  
Apricus Biosciences Announces the Launch of Its Topical Treatment for Erectile ...
SAN DIEGO, Aug. 18, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines to meet the needs of patients, today announced the launch in Germany of Vitaros�, Apricus' novel ...
Related articles »  
Big Movers: J. C. Penney Company (NYSE:JCP), Workday (NYSE:WDAY ...
On 8 AUG Apricus Biosciences, Inc. (NASDAQ:APRI) announced a multi-year partnership agreement with the Scleroderma Research Foundation or SRF to support the foundation's activities and the further progress of its groundbreaking research programs.
Fast Moving Stocks: NPS Pharmaceuticals (NASDAQ:NPSP), Home Depot ...
Apricus Biosciences Inc. (NASDAQ:APRI) was upgraded by Zacks from an �underperform� rating to a �neutral� rating in a research note issued on Thursday.
Vivus Up On Erectile Dysfunction Drug - What Should Investors Expect?
The key now is getting the name out there. As stated, the label gives Vivus a leg up on the competition in the United States. That being said, there is competition in Europe that works in minutes.
Related articles »  
Anacor Pharmaceuticals Appoints Wendell Wierenga to Its Board of Directors
In addition, Dr. Wierenga is a member of the boards of directors of XenoPort, Inc., Cytokinetics, Incorporated, Ocera Therapeutics, Inc., Apricus Biosciences, Inc. and Concert Pharmaceuticals, Inc. �The other members of the Board and I thank Paul for ...
Related articles »  
Momentum Stocks: Kinross Gold Corporation (NYSE:KGC), UTi Worldwide ...
Simpson Manufacturing Co., Inc. (NYSE:SSD) price to sales (P/S) ratio is 2.17. Apricus Biosciences (NASDAQ:APRI) released its earnings data on Tuesday.
Related articles »  
Shining on Major News : Twitter (NYSE:TWTR), RadioShack Corp. (NYSE:RSH ...
Zacks upgraded shares of Apricus Biosciences, Inc. (NASDAQ:APRI) from an underperform rating to a neutral rating in a research report sent to investors on Thursday morning.